Meta-analysis of TNF-α promoter − 238A/G polymorphism and SLE susceptibility

References

• Vyse TJ, Kotzin BL. Genetic basis of systemic lupus erythematosus. Curr Opin Immunol. 1996; 8:843–851.
   PubMed Web of Science ®Google Scholar
• Harley JB, Moser KL, Gaffney PM, Behrens TW. The genetics of human systemic lupus erythematosus. Curr Opin Immunol. 1998; 10:690–696.
   PubMed Web of Science ®Google Scholar
• Dunham I, Sargent CA, Trowsdale J, Campbell RD. Molecular mapping of the human major histocompatibility complex by pulsed-field gel electrophoresis. Proc Natl Acad Sci USA. 1987; 84:7237–7241.
   PubMed Web of Science ®Google Scholar
• Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 1992; 10:411–452.
   PubMed Web of Science ®Google Scholar
• Maury CP, Teppo AM. Tumor necrosis factor in the serum of patients with systemic lupus erythematosus. Arthritis Rheum. 1989; 32:146–150.
   PubMedGoogle Scholar
• Mageed RA, Isenberg DA. Tumour necrosis factor alpha in systemic lupus erythematosus and anti-DNA autoantibody production. Lupus. 2002; 11:850–855.
   PubMed Web of Science ®Google Scholar
• Gomez D, Correa PA, Gomez LM, Cadena J, Molina JF, Anaya JM. Th1/Th2 cytokines in patients with systemic lupus erythematosus: Is tumor necrosis factor alpha protective?. Semin Arthritis Rheum. 2004; 33:404–413.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997; 315:629–634.
   PubMed Web of Science ®Google Scholar
• Lee YH, Harley JB, Nath SK. Meta-analysis of TNF-alpha promoter − 308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet. 2006; 14:364–371.
   PubMed Web of Science ®Google Scholar
• Cochran WG. The combination of estimates from different experiments. Biometrics. 1954; 10:101–129.
   Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21:1539–1558.
   PubMed Web of Science ®Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22:719–748.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7:177–188.
   PubMed Web of Science ®Google Scholar
• Jiménez-Morales S, Velázquez-Cruz R, Ramírez-Bello J, Bonilla-González E, Romero-Hidalgo S, Escamilla-Guerrero G, Cuevas F, Espinosa-Rosales F, Martínez-Aguilar NE, Gómez-Vera J, Baca V, Orozco L. Tumor necrosis factor-alpha is a common genetic risk factor for asthma, juvenile rheumatoid arthritis, and systemic lupus erythematosus in a Mexican pediatric population. Hum Immunol. 2009; 70:251–256.
   PubMed Web of Science ®Google Scholar
• Hirankarn N, Avihingsanon Y, Wongpiyabovorn J. Genetic susceptibility to SLE is associated with TNF-α gene polymorphism − 863, but not − 308 and − 238, in Thai population. Inter J Immunogen. 2007; 34:425–430.
   Google Scholar
• McHugh NJ, Owen P, Cox B, Dunphy J, Welsh K. MHC class II, tumour necrosis factor alpha, and lymphotoxin alpha gene haplotype associations with serological subsets of systemic lupus erythematosus. Ann Rheum Dis. 2006; 65:488–494.
   PubMedGoogle Scholar
• Correa PA, Gomez LM, Cadena J, Anaya JM. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J Rheumatol. 2005; 32:219–224.
   PubMed Web of Science ®Google Scholar
• Parks CG, Pandey JP, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, Feghali-Bostwick CA, Cooper GS. Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: Associations and interaction with the interleukin-1alpha-889 C/T polymorphism. Hum Immunol. 2004; 65:622–631.
   PubMed Web of Science ®Google Scholar
• Zúñiga J, Vargas-Alarcón G, Hernández-Pacheco G, Portal-Celhay C, Yamamoto-Furusho JK, Granados J. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun. 2001; 2:363–366.
   PubMed Web of Science ®Google Scholar
• Rood MJ, van Krugten MV, Zanelli E, van der Linden MW, Keijsers V, Schreuder GM, Verduyn W, Westendorp RG, de Vries RR, Breedveld FC, Verweij CL, Huizinga TW. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum. 2000; 43:129–134.
   PubMed Web of Science ®Google Scholar
• D'Alfonso S, Colombo G, Della Bella S, Scorza R, Momigliano-Richiardi P. Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens. 1996; 47:551–555.
   Google Scholar
• Rudwaleit M, Tikly M, Khamashta M, Gibson K, Klinke J, Hughes G, Wordsworth P. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol. 1996; 23:1725–1728.
   PubMedGoogle Scholar
• Granados J, Zúñiga J, Acuña-Alonzo V, Rosetti F, Vargas-Alarcón G. Influence of alleles and haplotypes of the main histocompatibility complex on the susceptibility to systemic lupus erythematosus in the Mexican population. Gac Med Mex. 2006; 142:195–199.
   PubMedGoogle Scholar
• Brennan FM, Maini RN, Feldmann M. TNF alpha—a pivotal role in rheumatoid arthritis?. Br J Rheumatol. 1992; 31:293–298.
   PubMedGoogle Scholar
• Allen RD. Polymorphism of the human TNF-αlpha promoter—random variation or functional diversity?. Mol Immunol. 1999; 36:1017–1027.
   PubMed Web of Science ®Google Scholar
• Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Peña AS. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol. 1996; 43:456–463.
   PubMed Web of Science ®Google Scholar
• Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE, Galle PR, Maerker-Hermann E, Hoehler T. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol. 2000; 114:1180–1183.
   PubMed Web of Science ®Google Scholar
• Pociot F, D'Alfonso S, Compasso S, Scorza R, Richiardi PM. Functional analysis of a new polymorphism in the human TNF alpha gene promoter. Scand J Immunol. 1995; 42:501–504.
   PubMed Web of Science ®Google Scholar
• D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics. 1994; 39:150–154.
   PubMed Web of Science ®Google Scholar
• Wilson GA, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha (TNF-α) gene detectble by NcoI restriction of PCR product. Hum Mol Genet. 1992; 1:353–358.
   PubMedGoogle Scholar
• Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, Langermans JA, Breedveld FC, Verweij CL, van de Gaer L, Dams L, Crusius JB, García-Gonzalez A, van Oosten BW, Polman CH, Peña AS. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol. 1997; 72:149–153.
   PubMed Web of Science ®Google Scholar
• Jacob CO, McDevitt HO. Tumour necrosis factor-alpha in murine autoimmune ‘lupus’ nephritis. Nature. 1988; 331:356–358.
   PubMed Web of Science ®Google Scholar
• Gordon C, Ranges GE, Greenspan JS, Wofsy D. Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice. Clin Immunol Immunopathol. 1989; 52:421–434.
   PubMedGoogle Scholar
• Gordon C, Wofsy D. Effects of recombinant murine tumor necrosis factor-alpha on immune function. J Immunol. 1990; 144:1753–1758.
   PubMedGoogle Scholar
• Kontoyiannis D, Kollias G. Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor. Eur J Immunol. 2000; 30:2038–2047.
   PubMed Web of Science ®Google Scholar
• Boswell JM, Yui MA, Burt DW, Kelley VE. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J Immunol. 1988; 141:3050–3054.
   PubMed Web of Science ®Google Scholar
• Yokoyama H, Kreft B, Kelley VR. Biphasic increase in circulating and renal TNF-alpha in MRL-lpr mice with differing regulatory mechanisms. Kidney Int. 1995; 47:122–130.
   PubMed Web of Science ®Google Scholar
• Brennan DC, Yui MA, Wuthrich RP, Kelley VE. Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury. J Immunol. 1989; 143:3470–3475.
   PubMed Web of Science ®Google Scholar
• Edwards CKIII, Zhou T, Zhang J, Baker TJ, De M, Long RE, Borcherding DR, Bowlin TL, Bluethmann H, Mountz JD. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha. J Immunol. 1996; 157:1758–1772.
   PubMed Web of Science ®Google Scholar
• Deguchi Y, Kishimoto S. Tumour necrosis factor/cachectin plays a key role in autoimmune pulmonary inflammation in lupus-prone mice. Clin Exp Immunol. 1991; 85:392–395.
   PubMed Web of Science ®Google Scholar
• Su X, Zhou T, Yang P, Edwards CK, Mountz JD. Reduction of arthritis and pneumonitis in motheaten mice by soluble tumor necrosis factor receptor. Arthritis Rheum. 1998; 41:139–149.
   PubMed Web of Science ®Google Scholar
• Segal R, Dayan M, Zinger H, Mozes E. Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNF-alpha monoclonal antibody and by pentoxiphylline. Lupus. 2001; 10:23–31.
   PubMed Web of Science ®Google Scholar
• Campbell RD, Trowsdale J. Map of the human MHC. Immunol Today. 1993; 14:349–352.
   PubMedGoogle Scholar
• Lee YH, Ji JD, Song GG. Tumor necrosis factor-alpha promoter − 308 A/G polymorphism and rheumatoid arthritis susceptibility: A meta-analysis. J Rheumatol. 2007; 34:43–49.
   Google Scholar
• Wilson GA, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 1993; 177:557–560.
   PubMed Web of Science ®Google Scholar